{"id":"W3081339262","doi":"10.1200/jco.2009.27.15_suppl.519","title":"Anthracyclines in basal breast cancer: The NCIC-CTG trial MA5 comparing adjuvant CMF to CEF","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Toronto; BC Cancer Agency","funders":"","keywords":"Medicine; Epirubicin; Anthracycline; Breast cancer; Internal medicine; Cyclophosphamide; Oncology; Hazard ratio; Population; Cancer; Chemotherapy; Basal (medicine); Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002432027,0.0007465769,0.001337927,0.0004720062,0.0002322407,0.0008599869,0.0007209191,0.001121334,0.002796248],"category_scores_gemma":[0.003022359,0.0001994165,0.001735553,0.0004550343,0.0004687729,0.0004793591,0.0003782419,0.001523311,0.0003237678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001315305,"about_ca_system_score_gemma":0.0008098388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002766935,"about_ca_topic_score_gemma":0.007496079,"domain_scores_codex":[0.998796,0.0008659645,0.0000639461,0.0001043384,0.00007072924,0.00009904939],"domain_scores_gemma":[0.9988213,0.000445051,0.000280689,0.000104932,0.00006658661,0.0002814966],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9407331,0.001738668,0.009837913,0.001389109,0.005453121,0.00007712303,0.00009372726,0.001389293,0.002791635,0.0004268696,0.002885818,0.0331836],"study_design_scores_gemma":[0.7294922,0.1695749,0.0645149,0.0009380206,0.01748689,0.0003691019,0.0001916976,0.004195956,0.00284324,0.0009614206,0.009364217,0.00006739522],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9700118,0.02370233,0.0002990446,0.001248068,0.0002477772,0.0005602602,0.001178411,0.00003742568,0.002714838],"genre_scores_gemma":[0.9935142,0.002358507,0.0003357401,0.0009669038,0.0002015931,0.000299393,0.00143625,0.000006153037,0.0008811294],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002796248,"threshold_uncertainty_score":0.01286197,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09731894785661191,"score_gpt":0.479279693781526,"score_spread":0.3819607459249141,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}